Stock screenerAll disclosures →
EDGAR →
IDYA
Conviction 47HealthcareScan · Thu, Sep 24, 2026IDEAYA Biosciences, Inc. (IDYA) closed at $36.69 (-2.06%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 41, RS Rating 84, -13.6% from its 52-week high, +8.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
IDYA$36.69-2.06%
ResistanceSupportVol 14Insider sellVol MA14 902.13K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price36.69
Change-2.06%
Gap-0.13%
Rel volume1.59×
Avg volume838.86K
Avg $ vol32.41M
SMA 2038.87
SMA 5037.77
SMA 20033.96
Price vs 50-2.85%
Price vs 200+8.04%
MA stackmixed
50/200 cross—
Supertrenddown · 40.90
RSI (14)41
MACD hist-0.25
MACD cross—
Stoch %K / %D25 / 32
ADX (14)17
+DI / −DI21 / 30
RSI divergence—
MACD divergence—
ATR %3.88%
ADR %3.27%
52w high42.48
52w low25.67
From 52w high-13.63%
Above 52w low+42.93%
New 52w highNo
SqueezeOff
Bollinger width12.94%
%B0.07
Donchian pos16.91%
Donchian high42.10
Donchian low35.59
AVWAP (52w high)39.06
vs AVWAP high-6.08%
AVWAP (52w low)33.07
vs AVWAP low+10.95%
OBV trendDown
Chaikin MF (20)-0.24
Today vs 20d1.59×
Avg vol (14d)902.13K
Avg vol (20d)838.86K
Avg $ vol (20d)32.41M
Market cap3.54B
RS Rating84 / 99
RS 3m (vs SPY)-3.39%
RS 6m (vs SPY)+0.07%
RS line new highNo
Trend template4/8
Technical rank57.1
1 week-4.97%
1 month-13.63%
3 months+1.10%
6 months+16.88%
1 year+41.50%
YTD+8.39%
P/E-31.14
P/B2.95
P/S16.19
P/FCF-48.19
EPS-1.28
Div yield—
ROE-9.48%
ROA-8.68%
Debt/Eq—
Current10.45
EV/EBITDA-20.86
Gross margin—
Net margin-51.99%
Rev growth3024.43%
EPS growth58.58%
Price target54.44
Target upside48.38%
Analyst ratingBuy
Institutional119.53%
Ent. value3.27B
Revenue8.86M
Net income-112.45M
Gross profit—
Free cash flow-73.47M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out87.86M
Employees145
ListedThu, May 23, 2019
Free float87.08M
Float %99.1%
Short interest10.1M
Days to cover12.2d
Short volume43.1%
Squeeze score59 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.22 vs −$1.18
Last surprise-3.4% miss
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank57.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance42.08
Support35.11
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- IDEAYA Biosciences Sinks As Rally Unravels FastTipRanks · Tue, Sep 22, 2026
- Cantor Fitzgerald reiterates Ideaya Biosciences stock ratingInvesting.com · Tue, Sep 22, 2026
- How (IDYA) Movements Inform Risk Allocation ModelsStock Traders Daily · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in IDYA
No recent disclosed trades by Congress in IDYA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IDYA · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ruiz Briseno Andres Chief Accounting Officer · Common Stock · 2026-07-07 | Exercise | 9.55K | $123K | 2026-07-07 | 2026-07-09 |
Ruiz Briseno Andres Chief Accounting Officer · Common Stock · 2026-07-07 | Sell | 9.55K | $382K | 2026-07-07 | 2026-07-09 |
Ruiz Briseno Andres Chief Accounting Officer · Stock Option (Right to Buy) · 2026-07-07 | Exercise | 9.55K | — | 2026-07-07 | 2026-07-09 |
Hampton Malcolm Garret Director · Stock Option (right to buy) · 2026-06-16 | Grant | 20K | — | 2026-06-16 | 2026-06-18 |
MACKEY CATHERINE J Director · Stock Option (right to buy) · 2026-06-16 | Grant | 20K | — | 2026-06-16 | 2026-06-18 |
Morrison Scott W Director · Stock Option (right to buy) · 2026-06-16 | Grant | 20K | — | 2026-06-16 | 2026-06-18 |
ROSEN TERRY J Director · Stock Option (right to buy) · 2026-06-16 | Grant | 20K | — | 2026-06-16 | 2026-06-18 |
Stein Jeffrey Director · Stock Option (right to buy) · 2026-06-16 | Grant | 20K | — | 2026-06-16 | 2026-06-18 |
YARNO WENDY L Director · Stock Option (right to buy) · 2026-06-16 | Grant | 20K | — | 2026-06-16 | 2026-06-18 |
SEC filings
EDGAR filings in IDYA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.